Tower Research Capital LLC (Trc) Century Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,809 shares of IPSC stock, worth $6,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,809
Previous 7,100
38.15%
Holding current value
$6,473
Previous $12,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IPSC
# of Institutions
71Shares Held
33.6MCall Options Held
9.7KPut Options Held
1.5K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.57 Million1.48% of portfolio
-
Casdin Capital, LLC New York, NY5.19MShares$3.43 Million0.45% of portfolio
-
Vr Adviser, LLC New York, NY3.96MShares$2.61 Million0.66% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.57 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $38.9M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...